HANDOK Inc.
002390.KS
Get informed when a big investor buys or sells
+ FollowMarket Cap$111.72B
Close$
Share Statistics
| Market cap | $111.72 Billion |
|---|---|
| Enterprise Value | $465.08 Billion |
| Dividend Yield | $200.00 (2.33%) |
| Earnings per Share | $-162.61 |
| Beta | 0.26 |
| Outstanding Shares | 13,764,000 |
Return
| Return on Equity | -3.70% |
|---|---|
| Return on Assets | -1.20% |
| Return on Invested Capital | 4.16% |
Valuation & Multiples
| P/E Ratio | -11.33 |
|---|---|
| PEG | -11.34 |
| Price to Sales | 0.2 |
| Price to Book Ratio | 0.45 |
| Enterprise Value to Revenue | 0.83 |
| Enterprise Value to EBIT | 28.52 |
| Enterprise Value to Net Income | -50 |
| Total Debt to Enterprise | 0.81 |
| Debt to Equity | 1.49 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 30, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$134.00 B
Average shareholder expectationNext Earnings Call
Expected Date
November 18, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$134.00 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About HANDOK Inc.
951 employees
CEO: Cho Jae-cheon HANDOK Inc. operates as a pharmaceutical company. The company provides prescription and OTC drugs; medical devices, such as blood pressure monitors, cholesterol monitoring systems, insulin pumps, self-monitoring system of blood glucose, ...